Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms

British Journal of Haematology

Volumn 144, Issue 6, 2009, Pages 965-967

  Za, Tommaso ^a   Fiorini, Alessia ^a   Rossi, Elena ^a   Ciminello, Angela ^a   Chiusolo, Patrizia ^a   Leone, Giuseppe ^a   De Stefano, Valerio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

JAK2 V617F mutation; Thrombophilia; Venous thrombosis

Indexed keywords

JANUS KINASE 2;

ADULT; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; LEG THROMBOSIS; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; PREVALENCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 60649107016     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07537.x     Document Type: Letter

References (10)

1. Colaizzo, D., Amitrano, L., Iannaccone, L., Vergura, P., Cappucci, F., Grandone, E., Guardascione, M.A. Margaglione, M. (2007) Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. Journal of Medical Genetics, 44, 412 416.
2. Dahabreh, I.J., Zoi, K., Giannouli, S., Zoi, C., Loukopoulos, D. Voulgarelis, M. (2009) Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leukemia Research, 33, 67 73.
3. De Stefano, V., Fiorini, A., Rossi, E., Za, T., Farina, G., Chiusolo, P., Sica, S. Leone, G. (2007) Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. Journal of Thrombosis and Haemostasis, 5, 708 714.
4. Pardanani, A., Lasho, T.L., Hussein, K., Schwager, S., Finke, C., Hussein, K., Pruthi, R.K. Tefferi, A. (2008) JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients. Mayo Clinic Proceedings, 83, 457 459.
5. Regina, S., Herault, O., D'Alteroche, L., Binet, C. Gruel, Y. (2007) JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. Journal of Thrombosis and Haemostasis, 5, 859 861.
6. Remacha, A.F., Estivill, C., Sarda, M.P., Mateo, J., Souto, J.C., Canals, C., Nomdedéu, J. Fontcuberta, J. (2007) The V617F mutation of JAK2 is very uncommon in patients with thrombosis. Haematologica, 92, 285 286.
7. Rossi, D., Cresta, S., Destro, T., Vendramin, C., Bocchetta, S., De Paoli, L., Cerri, M., Lunghi, M. Gaidano, G. (2007) JAK2V617F in idiopathic venous thromboembolism occurring in the absence of inherited or acquired thrombophilia. British Journal of Haematology, 138, 813 814.
8. Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H.M., Barbui, T., Hanson, C.A., Barosi, G., Verstovsek, S., Birgegard, G., Mesa, R., Reilly, J.T., Gisslinger, H., Vannucchi, A.M., Cervantes, F., Finazzi, G., Hoffman, R., Gilliland, D.G., Bloomfield, C.D. Vardiman, J.W. (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood, 110, 1092 1097.
9. Ugo, V., Le Gal, G., Lecucq, L., Mottier, D. Oger, E. for the EDITH Collaborative Study Group (2008) Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism. Journal of Thrombosis and Haemostasis, 6, 203 205.
10. Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Longo, G., Pancrazzi, A., Ponziani, V., Bogani, C., Rossi Ferrini, P., Rambaldi, A., Guerini, V., Bosi, A. Barbui, T. for the MPD Research Consortium (2007) Prospective identification of high-risk polycythemia vera patients based on JAK2 V617F allele burden. Leukemia, 21, 1952 1959.